Crown (CCK) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Third quarter 2024 net sales were $3,074 million, nearly flat year-over-year, with higher beverage and food can shipments in North America offset by lower volumes elsewhere and $9 million in unfavorable currency translation.
Global beverage segment income rose 23% on 5% global volume growth, with notable performance in Americas and Europe.
Net loss attributable to Crown Holdings was $175 million, reflecting $517 million in pension settlement charges, compared to net income of $159 million last year.
Adjusted for pension settlements, operating income improved year-over-year, driven by higher beverage can shipments and improved manufacturing performance in Americas and Europe.
Company continues to focus on sustainability, cost management, and capital discipline amid ongoing macroeconomic and geopolitical uncertainties.
Financial highlights
Net sales were flat year-over-year at $3.1 billion, with beverage can and North American food can volume gains offset by declines elsewhere.
Segment income increased to $472 million from $430 million year-over-year.
GAAP loss per share was $1.47 due to a non-cash pension settlement charge; adjusted EPS was $1.99, up 15% sequentially.
Free cash flow reached $668 million through nine months, $450 million ahead of the prior year period.
Operating cash flow for nine months was $897 million, up from $832 million in 2023.
Outlook and guidance
Full-year adjusted EPS guidance raised to $6.25–$6.35 from $6–$6.25.
Fourth quarter adjusted EPS projected at $1.45–$1.55.
2024 full-year adjusted free cash flow expected to be at least $750 million, with net leverage below 3x by year-end.
Capital spending for 2024 expected to be no more than $450 million.
Company expects to meet current and future demand growth with existing capital base.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025